Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 110651-110700 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03194815
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
PHASE2
Recruiting
70 participants
Started: Nov 1, 2017 · Completed: Mar 31, 2027
2 conditions
2 sponsors
10 locations
NCT04324008
Clinical Comparison of Different Flowable Resin Composites
NA
Active, not recruiting
28 participants
Started: Nov 1, 2017 · Completed: Nov 1, 2024
1 condition
1 sponsor
1 location
NCT04263857
Register of Blood Stem Cell Transplantation
N/A
Recruiting
5,000 participants
Started: Nov 1, 2017 · Completed: Nov 30, 2037
1 condition
1 sponsor
1 location
NCT03708627
Bimatoprost as a Treatment for Graves' Orbitopathy
EARLY_PHASE1
Recruiting
3 participants
Started: Nov 1, 2017 · Completed: Jul 1, 2031
1 condition
1 sponsor
1 location
NCT05945719
Discrimination Harassment of Pain Staff Caused by Patient
N/A
Recruiting
1,000 participants
Started: Nov 1, 2017 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03333122
Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes
N/A
Active, not recruiting
575 participants
Started: Oct 31, 2017 · Completed: Jan 31, 2030
1 condition
1 sponsor
1 location
NCT03336333
A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL
PHASE3
Active, not recruiting
590 participants
Started: Oct 31, 2017 · Completed: Sep 30, 2026
2 conditions
1 sponsor
158 locations
NCT03273881
Intrapartum Glucose and Insulin Compared to Glucose Alone in Diabetic Women
NA
Recruiting
200 participants
Started: Oct 31, 2017 · Completed: Dec 31, 2023
2 conditions
2 sponsors
1 location
NCT03310918
A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy
NA
Recruiting
320 participants
Started: Oct 31, 2017 · Completed: Dec 1, 2024
2 conditions
1 sponsor
2 locations
NCT03065387
Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation
PHASE1
Active, not recruiting
93 participants
Started: Oct 31, 2017 · Completed: Oct 1, 2025
10 conditions
2 sponsors
1 location
NCT04219670
Inpatient Stroke Recovery Using Sensors
N/A
Recruiting
400 participants
Started: Oct 31, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03334708
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
N/A
Recruiting
700 participants
Started: Oct 30, 2017 · Completed: Oct 30, 2025
4 conditions
4 sponsors
13 locations
NCT03260465
Clinical Study With the seleXys PC and the RM Pressfit Vitamys Cup
NA
Active, not recruiting
53 participants
Started: Oct 30, 2017 · Completed: Aug 31, 2025
2 conditions
1 sponsor
1 location
NCT03260491
U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
PHASE1
Recruiting
309 participants
Started: Oct 30, 2017 · Completed: Dec 31, 2026
1 condition
2 sponsors
37 locations
NCT03362801
SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly
NA
Recruiting
69 participants
Started: Oct 30, 2017 · Completed: Feb 1, 2026
2 conditions
1 sponsor
3 locations
NCT03297281
Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)
NA
Recruiting
389 participants
Started: Oct 30, 2017 · Completed: May 31, 2026
2 conditions
3 sponsors
1 location
NCT03167437
An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
PHASE1/PHASE2
Recruiting
35 participants
Started: Oct 30, 2017 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT03635645
Experimental and Clinical Studies of Retinal Stimulation
NA
Recruiting
20 participants
Started: Oct 30, 2017 · Completed: Oct 30, 2023
1 condition
2 sponsors
1 location
NCT03319901
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
PHASE1/PHASE2
Recruiting
82 participants
Started: Oct 30, 2017 · Completed: Apr 30, 2027
1 condition
2 sponsors
5 locations
NCT03321539
Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma
PHASE3
Active, not recruiting
216 participants
Started: Oct 30, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
4 locations
NCT03029884
Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain
NA
Active, not recruiting
4 participants
Started: Oct 28, 2017 · Completed: Jun 30, 2026
4 conditions
3 sponsors
1 location
NCT06666816
Observational Study to Observe Variations of Gait Parameters in Patients with Neuromuscular Diseases
N/A
Recruiting
120 participants
Started: Oct 27, 2017 · Completed: Dec 31, 2026
4 conditions
1 sponsor
2 locations
NCT03299049
Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults
PHASE3
Active, not recruiting
1,049 participants
Started: Oct 27, 2017 · Completed: Dec 31, 2029
1 condition
2 sponsors
118 locations
NCT03310424
Transcriptomic and Next Generation Sequencing Approaches to Infection With Treponema Pallidum
N/A
Active, not recruiting
46 participants
Started: Oct 27, 2017 · Completed: Aug 31, 2024
1 condition
1 sponsor
1 location
NCT03449914
The GOLD Study: G8 in OLDer Patients
N/A
Active, not recruiting
109 participants
Started: Oct 26, 2017 · Completed: Jul 31, 2024
1 condition
2 sponsors
1 location
NCT02703662
Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction
PHASE2/PHASE3
Recruiting
90 participants
Started: Oct 26, 2017 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03313804
Priming Immunotherapy in Advanced Disease With Radiation
PHASE2
Active, not recruiting
76 participants
Started: Oct 26, 2017 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT03320252
Endurant CHevAr New Indication Trial: ENCHANT
N/A
Active, not recruiting
150 participants
Started: Oct 26, 2017 · Completed: Jul 31, 2030
1 condition
1 sponsor
26 locations
NCT03298737
Visual Attention and Eye Movements
N/A
Enrolling by invitation
20 participants
Started: Oct 26, 2017 · Completed: Sep 1, 2026
1 condition
1 sponsor
1 location
NCT03203473
Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)
PHASE2
Active, not recruiting
85 participants
Started: Oct 26, 2017 · Completed: Dec 28, 2025
1 condition
2 sponsors
8 locations
NCT03157934
Schlaganfallkonsortium Rhein-Neckar (Stroke Consortium Rhine-Neckar)
N/A
Recruiting
12,000 participants
Started: Oct 26, 2017 · Completed: Mar 31, 2024
3 conditions
2 sponsors
1 location
NCT06336889
Pelvic Angioembolization: A Prospective Multi-Institutional Study (Data From All Campuses Will be Used)
N/A
Recruiting
400 participants
Started: Oct 26, 2017 · Completed: Oct 31, 2024
1 condition
1 sponsor
1 location
NCT03329274
Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
N/A
Recruiting
250 participants
Started: Oct 26, 2017 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT03270072
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients
N/A
Recruiting
100 participants
Started: Oct 26, 2017 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT03227146
Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
PHASE2
Active, not recruiting
14 participants
Started: Oct 25, 2017 · Completed: Aug 31, 2025
1 condition
6 sponsors
6 locations
NCT03109444
Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound
N/A
Recruiting
75 participants
Started: Oct 25, 2017 · Completed: Oct 1, 2024
2 conditions
1 sponsor
1 location
NCT03218488
A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis
N/A
Active, not recruiting
135 participants
Started: Oct 25, 2017 · Completed: Aug 31, 2032
1 condition
1 sponsor
30 locations
NCT02636569
Topical Chemoprevention of Skin Cancer Biomarkers
PHASE2
Active, not recruiting
24 participants
Started: Oct 25, 2017 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT02879695
Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia
PHASE1
Active, not recruiting
28 participants
Started: Oct 25, 2017 · Completed: Jul 18, 2026
4 conditions
1 sponsor
7 locations
NCT03182244
A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
PHASE3
Active, not recruiting
276 participants
Started: Oct 25, 2017 · Completed: Mar 31, 2026
1 condition
1 sponsor
49 locations
NCT02977468
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
PHASE1
Recruiting
15 participants
Started: Oct 25, 2017 · Completed: Dec 31, 2025
1 condition
2 sponsors
3 locations
NCT03375242
Safety and Efficacy of Xalkori ROS1
N/A
Recruiting
100 participants
Started: Oct 25, 2017 · Completed: Mar 26, 2027
1 condition
1 sponsor
1 location
NCT03229564
Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children
PHASE2
Active, not recruiting
12 participants
Started: Oct 25, 2017 · Completed: Jun 30, 2028
1 condition
6 sponsors
4 locations
NCT03139305
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
PHASE1
Active, not recruiting
30 participants
Started: Oct 24, 2017 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT03434392
QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
NA
Recruiting
500 participants
Started: Oct 24, 2017 · Completed: Jun 30, 2026
2 conditions
3 sponsors
3 locations
NCT04187729
Precision Genomics Medicine Biobank
N/A
Recruiting
100,000 participants
Started: Oct 24, 2017 · Completed: Oct 24, 2077
1 condition
1 sponsor
1 location
NCT03880708
China Inherited Ventricular Arrhythmias Registry
N/A
Recruiting
500 participants
Started: Oct 24, 2017 · Completed: Oct 24, 2027
1 condition
10 sponsors
1 location
NCT03318094
Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in Obesity
PHASE1
Active, not recruiting
36 participants
Started: Oct 24, 2017 · Completed: Nov 30, 2025
3 conditions
1 sponsor
1 location
NCT02951130
Milrinone in Congenital Diaphragmatic Hernia
PHASE2
Active, not recruiting
66 participants
Started: Oct 24, 2017 · Completed: Mar 31, 2025
4 conditions
2 sponsors
19 locations
NCT03128034
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
PHASE1/PHASE2
Recruiting
75 participants
Started: Oct 24, 2017 · Completed: Mar 31, 2029
12 conditions
2 sponsors
1 location
Previous
1
More pages
2211
2212
2213
2214
2215
2216
2217
More pages
2369
Next